FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Marcel Bally

Research Profile

Chemicals & Drugs

Living Beings

Mouse

Anatomy

Tumor Cell Line

Concepts & Ideas

Procedures

Devices

Drug Delivery Systems

Co-author Network

Publications

TOP 3
Nilesh A Patankar; Julia Pritchard; Mariska van Grinsven; Maryam Osooly; Marcel B Bally
Topotecan and doxorubicin combination to treat recurrent ovarian cancer: the influence of drug exposure time and delivery systems to achieve optimum therapeutic activity.
Nilesh A Patankar; Dita Strutt; Dawn Waterhouse; Malathi Anantha; Marcel B Bally
Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.
Jennifer I Hare; Robert W Neijzen; Murray S Webb; Theresa M Allen; Malathi Anantha; Marcel B Bally; Nancy Dos Santos; Natashia Harasym; Dawn N Waterhouse
Treatment of colorectal cancer using a combination of liposomal irinotecan (irinophore c™) and 5-Fluorouracil.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Marcel Bally (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Nilesh A Patankar; Julia Pritchard; Mariska van Grinsven; Maryam Osooly; Marcel B Bally
Topotecan and doxorubicin combination to treat recurrent ovarian cancer: the influence of drug exposure time and delivery systems to achieve optimum therapeutic activity.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(4):865-77.
2013: Nilesh A Patankar; Dita Strutt; Dawn Waterhouse; Malathi Anantha; Marcel B Bally
Topophore C: a liposomal nanoparticle formulation of topotecan for treatment of ovarian cancer.
Investigational new drugs 2013;31(1):46-58.
2013: Jennifer I Hare; Robert W Neijzen; Murray S Webb; Theresa M Allen; Malathi Anantha; Marcel B Bally; Nancy Dos Santos; Natashia Harasym; Dawn N Waterhouse
Treatment of colorectal cancer using a combination of liposomal irinotecan (irinophore c™) and 5-Fluorouracil.
PloS one 2013;8(4):e62349.
2013: Maite Verreault; Corinna Warburton; Sherry A Weppler; Dana Masin; Amelia Stegeman; Dita Strutt; Marcel B Bally
Combined RNAi-Mediated Suppression of Rictor and EGFR Resulted in Complete Tumor Regression in an Orthotopic Glioblastoma Tumor Model.
PloS one 2013;8(3):e59597.
2013: Richard W Ahn; Michael J Avram; Marcel B Bally; Susan L Barrett; Haimei Chen; Leo I Gordon; Jennifer K Jozefik; Andrew P Mazar; Thomas V O'Halloran; Meera R Raja; Lonnie D Shea; Lidia Spaho; Jane N Winter; Teresa K Woodruff
Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo.
PloS one 2013;8(3):e58491.
2012: Alain Gulenga Musende; Catherine A Wood; Hans Adomat; Marcel B Bally; Andy Eberding; Ladan Fazli; Antonio Hurtado-coll; William Jia; Emma S Tomlinson Guns
A novel oral dosage formulation of the ginsenoside aglycone protopanaxadiol exhibits therapeutic activity against a hormone-insensitive model of prostate cancer.
Anti-cancer drugs 2012;23(5):543-52.
2012: Maite Verreault; Dawn Waterhouse; Donald T T Yapp; Malathi Anantha; Dana Masin; D Strutt; Marcel B Bally
Irinophore C™, a lipid-based nanoparticulate formulation of irinotecan, is more effective than free irinotecan when used to treat an orthotopic glioblastoma model.
Journal of controlled release : official journal of the Controlled Release Society 2012;158(1):34-43.
2011: Dawn Waterhouse; Donald T T Yapp; Malathi Anantha; Brent Sutherland; Maite Verreault; Marcel B Bally
Lipid-based nanoformulation of irinotecan: dual mechanism of action allows for combination chemo/angiogenic therapy.
Nanomedicine (London, England) 2011;6(9):1645-54.
2011: Jesse Popov; Catherine Tucker; Christopher Turner; Marcel B Bally; Gigi Chiu; Anita I Kapanen; Richard J Klasa; Rebecca Ng; Ghania Chikh
Multivalent rituximab lipid nanoparticles as improved lymphoma therapies: indirect mechanisms of action and in vivo activity.
Nanomedicine (London, England) 2011;6(9):1575-91.
2011: Victor W Ho; Anderson Hsu; Marcel B Bally; June Lai; Kelvin Leung; Wendy Lin; Beryl Luk; Andrew I Minchinton; Brad H Nelson; Sung Yuan Shen; Laura M Sly; Dawn Waterhouse; Gerald Krystal
A low carbohydrate, high protein diet slows tumor growth and prevents cancer initiation.
Cancer research 2011;71(13):4484-93.
2011: Jessica Kalra; Malathi Anantha; Corinna Warburton; Dawn Waterhouse; Hong Yan; Young-Joo Yang; Dita Strut; Maryam Osooly; Dana Masin; Marcel B Bally
Validating the use of a luciferase labeled breast cancer cell line, MDA435LCC6, as a means to monitor tumor progression and to assess the therapeutic activity of an established anticancer drug, docetaxel (Dt) alone or in combination with the ILK inhibitor, QLT0267.
Cancer biology & therapy 2011;11(9):826-38.
2011: Anitha M Thomas; Anita I Kapanen; Jennifer I Hare; Euan Ramsay; Katarina Edwards; Göran Karlsson; Marcel B Bally
Development of a liposomal nanoparticle formulation of 5-fluorouracil for parenteral administration: formulation design, pharmacokinetics and efficacy.
Journal of controlled release : official journal of the Controlled Release Society 2011;150(2):212-9.
2011: Wieslawa H Dragowska; Yannick Franssen; Karen A Gelmon; Anita I Kapanen; Guido J J Kierkels; Dana Masin; Andrew I Minchinton; Mohammed A Qadir; Sherry A Weppler; Ling Yan Wong; Jennifer H E Baker; Marcel B Bally
The combination of gefitinib and RAD001 inhibits growth of HER2 overexpressing breast cancer cells and tumors irrespective of trastuzumab sensitivity.
BMC cancer 2011;11():420.
2011: Maite Verreault; Dita Strutt; Dana Masin; Malathi Anantha; Andrew Yung; Piotr Kozlowski; Dawn Waterhouse; Marcel B Bally; Donald T Yapp
Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.
BMC cancer 2011;11():124.
2010: J Kalra; B W Sutherland; A L Stratford; Wieslawa H Dragowska; Karen Gelmon; Shoukat Dedhar; Sandra E Dunn; Marcel B Bally
Suppression of Her2/neu expression through ILK inhibition is regulated by a pathway involving TWIST and YB-1.
Oncogene 2010;29(48):6343-56.
2010: Alain G Musende; Andy Eberding; William Jia; Euan Ramsay; Marcel B Bally; Emma Tomlinson Guns
Rh2 or its aglycone aPPD in combination with docetaxel for treatment of prostate cancer.
The Prostate 2010;70(13):1437-47.
2010: Igor V Zhigaltsev; Geoff Winters; Masuna Srinivasulu; Jason Crawford; Matthew Wong; Lawrence Amankwa; Dawn Waterhouse; Dana Masin; Murray Webb; Natashia Harasym; Lindsay Heller; Marcel B Bally; Marco A Ciufolini; Pieter R Cullis; Norbert Maurer
Development of a weak-base docetaxel derivative that can be loaded into lipid nanoparticles.
Journal of controlled release : official journal of the Controlled Release Society 2010;144(3):332-40.
2010: Emmanuel A Ho; Euan Ramsay; Mihaela Ginj; Malathi Anantha; Isaiah Bregman; Jonathan Sy; Janet Woo; Maryam Osooly-Talesh; Donald T Yapp; Marcel B Bally
Characterization of cationic liposome formulations designed to exhibit extended plasma residence times and tumor vasculature targeting properties.
Journal of pharmaceutical sciences 2010;99(6):2839-53.
2010: Brian Banno; Ludger M Ickenstein; Gigi Chiu; Marcel B Bally; Jenifer Thewalt; Elana Brief; Ellen K Wasan
The functional roles of poly(ethylene glycol)-lipid and lysolipid in the drug retention and release from lysolipid-containing thermosensitive liposomes in vitro and in vivo.
Journal of pharmaceutical sciences 2010;99(5):2295-308.
2009: Alain G Musende; Andy Eberding; Catherine Wood; Hans Adomat; Ladan Fazli; Antonio Hurtado-coll; William Jia; Marcel B Bally; Emma Tomlinson Guns
Pre-clinical evaluation of Rh2 in PC-3 human xenograft model for prostate cancer in vivo: formulation, pharmacokinetics, biodistribution and efficacy.
Cancer chemotherapy and pharmacology 2009;64(6):1085-95.
2009: Maite Verreault; Marcel B Bally
siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing.
Oligonucleotides 2009;19(2):129-40.
2008: Jennifer H E Baker; Jeffrey Lam; Alaistair H Kyle; Jonathan Sy; Thomas Oliver; Steven J Co; Wieslawa H Dragowska; Euan Ramsay; Malathi Anantha; Thomas J Ruth; Michael J Adam; Andrew Yung; Piotr Kozlowski; Andrew I Minchinton; Sylvia S W Ng; Marcel B Bally; Donald T T Yapp
Irinophore C, a novel nanoformulation of irinotecan, alters tumor vascular function and enhances the distribution of 5-fluorouracil and doxorubicin.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(22):7260-71.
2008: Catherine A Tucker; Anita I Kapanen; Ghania Chikh; Brad G Hoffman; Alastair H Kyle; Ian M Wilson; Dana Masin; Randy D Gascoyne; Marcel B Bally; Richard J Klasa
Silencing Bcl-2 in models of mantle cell lymphoma is associated with decreases in cyclin D1, nuclear factor-kappaB, p53, bax, and p27 levels.
Molecular cancer therapeutics 2008;7(4):749-58.
2008: Paul C McDonald; Arusha Oloumi; Julia Mills; Iveta Dobreva; Mykola Maidan; Virginia Gray; Elizabeth D Wederell; Marcel B Bally; Leonard J Foster; Shoukat Dedhar
Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
Cancer research 2008;68(6):1618-24.
2008: Euan Ramsay; Jehan Alnajim; Malathi Anantha; Jason Zastre; Hong Yan; Murray Webb; Dawn Waterhouse; Marcel B Bally
A novel liposomal irinotecan formulation with significant anti-tumour activity: use of the divalent cation ionophore A23187 and copper-containing liposomes to improve drug retention.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2008;68(3):607-17.
2008: Euan C Ramsay; Malathi Anantha; Jason Zastre; Marieke Meijs; Jet Zonderhuis; Dita Strutt; Murray S Webb; Dawn Waterhouse; Marcel B Bally
Irinophore C: a liposome formulation of irinotecan with substantially improved therapeutic efficacy against a panel of human xenograft tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(4):1208-17.
2008: Janet Woo; Gigi Chiu; Göran Karlsson; Ellen K Wasan; Ludger M Ickenstein; Katarina Edwards; Marcel B Bally
Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes.
International journal of pharmaceutics 2008;349(1-2):38-46.
2008: Lincoln A Edwards; Janet Woo; Lynsey A Huxham; Maite Verreault; Wieslawa H Dragowska; Gigi Chiu; Ashish Rajput; Alastair H Kyle; Jessica Kalra; Donald T T Yapp; Hong Yan; Andrew I Minchinton; David Huntsman; Tim Daynard; Dawn Waterhouse; B Thiessen; Shoukat Dedhar; Marcel B Bally
Suppression of VEGF secretion and changes in glioblastoma multiforme microenvironment by inhibition of integrin-linked kinase (ILK).
Molecular cancer therapeutics 2008;7(1):59-70.
2007: Wieslawa H Dragowska; Maite Verreault; Donald T T Yapp; Corinna Warburton; Lincoln Edwards; Euan C Ramsay; Lynsey A Huxham; Andrew I Minchinton; Karen Gelmon; Marcel B Bally
Decreased levels of hypoxic cells in gefitinib treated ER+ HER-2 overexpressing MCF-7 breast cancer tumors are associated with hyperactivation of the mTOR pathway: therapeutic implications for combination therapy with rapamycin.
Breast cancer research and treatment 2007;106(3):319-31.
2007: K To; Y Zhao; H Jiang; K Hu; M Wang; Joyce Wu; Cathy Lee; Daniel Yokom; A L Stratford; U Klinge; P R Mertens; Ching-Shih Chen; Marcel B Bally; D Yapp; Sandra E Dunn
The phosphoinositide-dependent kinase-1 inhibitor 2-amino-N-[4-[5-(2-phenanthrenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]phenyl]-acetamide (OSU-03012) prevents Y-box binding protein-1 from inducing epidermal growth factor receptor.
Molecular pharmacology 2007;72(3):641-52.
2007: Nancy Dos Santos; Christine Allen; Anne-Marie Doppen; Malathi Anantha; Kelly A K Cox; Ryan C Gallagher; Göran Karlsson; Katarina Edwards; Gail Kenner; Lacey Samuels; Murray S Webb; Marcel B Bally
Influence of poly(ethylene glycol) grafting density and polymer length on liposomes: relating plasma circulation lifetimes to protein binding.
Biochimica et biophysica acta 2007;1768(6):1367-77.
2007: Jason Zastre; Malathi Anantha; Euan Ramsay; Marcel B Bally
Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.
Cancer chemotherapy and pharmacology 2007;60(1):91-102.
2007: Gigi Chiu; Lincoln A Edwards; Anita I Kapanen; Melina M Malinen; Wieslawa H Dragowska; Corinna Warburton; Ghania Chikh; Karen Y Y Fang; Sophia Tan; Jonathan Sy; Catherine Tucker; Dawn Waterhouse; Richard J Klasa; Marcel B Bally
Modulation of cancer cell survival pathways using multivalent liposomal therapeutic antibody constructs.
Molecular cancer therapeutics 2007;6(3):844-55.
2007: Paul G Tardi; Ryan C Gallagher; Sharon A Johnstone; Natashia Harasym; Murray Webb; Marcel B Bally; Lawrence D Mayer
Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo.
Biochimica et biophysica acta 2007;1768(3):678-87.
2007: Murray S Webb; Sharon A Johnstone; Tara J Morris; Allison Kennedy; Ryan Gallagher; Natashia Harasym; Troy O Harasym; Clifford R Shew; Paul G Tardi; Wieslawa H Dragowska; Lawrence D Mayer; Marcel B Bally
In vitro and in vivo characterization of a combination chemotherapy formulation consisting of vinorelbine and phosphatidylserine.
European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V 2007;65(3):289-99.
2007: Ana Ponce Kiess; Benjamin L Viglianti; Daohai Yu; Pavel Yarmolenko; Charles R Michelich; Janet Woo; Marcel B Bally; Mark Dewhirst
Magnetic resonance imaging of temperature-sensitive liposome release: drug dose painting and antitumor effects.
Journal of the National Cancer Institute 2007;99(1):53-63.
2006: Euan Ramsay; Jehan Alnajim; Malathi Anantha; Amandeep S Taggar; Anitha Thomas; Katarina Edwards; Göran Karlsson; Murray Webb; Marcel B Bally
Transition metal-mediated liposomal encapsulation of irinotecan (CPT-11) stabilizes the drug in the therapeutically active lactone conformation.
Pharmaceutical research 2006;23(12):2799-808.
2006: Sebastian Cogswell; Stuart Berger; Dawn Waterhouse; Marcel B Bally; Ellen K Wasan
A parenteral econazole formulation using a novel micelle-to-liposome transfer method: in vitro characterization and tumor growth delay in a breast cancer xenograft model.
Pharmaceutical research 2006;23(11):2575-85.
2006: Benjamin L Viglianti; Ana Ponce Kiess; Charles R Michelich; Daohai Yu; Sheela A Abraham; Linda Sanders; Pavel Yarmolenko; Thies Schroeder; James R MacFall; Daniel P Barboriak; O Michael Colvin; Marcel B Bally; Mark Dewhirst
Chemodosimetry of in vivo tumor liposomal drug concentration using MRI.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2006;56(5):1011-8.
2006: Dawn Waterhouse; Marcel B Bally
Temporal targeting in cancer: combined chemotherapy and antiangiogenic therapy.
Nanomedicine (London, England) 2006;1(3):359-63.
2006: Dawn Waterhouse; Karen Gelmon; Richard J Klasa; Kim Chi; D Huntsman; Euan Ramsay; Ellen K Wasan; L Edwards; C Tucker; Jason Zastre; Y Z Wang; Y Z Zhang; Donald T T Yapp; Wieslawa H Dragowska; S Dunn; Shoukat Dedhar; Marcel B Bally
Development and assessment of conventional and targeted drug combinations for use in the treatment of aggressive breast cancers.
Current cancer drug targets 2006;6(6):455-89.
2006: Amandeep S Taggar; Jehan Alnajim; Malathi Anantha; Anitha Thomas; Murray Webb; Euan Ramsay; Marcel B Bally
Copper-topotecan complexation mediates drug accumulation into liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2006;114(1):78-88.
2006: Maite Verreault; Murray S Webb; Euan C Ramsay; Marcel B Bally
Gene silencing in the development of personalized cancer treatment: the targets, the agents and the delivery systems.
Current gene therapy 2006;6(4):505-33.
2006: Lawrence D Mayer; Troy O Harasym; Paul G Tardi; Natashia Harasym; Clifford R Shew; Sharon A Johnstone; Euan C Ramsay; Marcel B Bally; Andrew S Janoff
Ratiometric dosing of anticancer drug combinations: controlling drug ratios after systemic administration regulates therapeutic activity in tumor-bearing mice.
Molecular cancer therapeutics 2006;5(7):1854-63.
2006: Catherine A Tucker; Gwyn Bebb; Richard J Klasa; Mukesh Chhanabhai; Valia Lestou; Douglas E Horsman; Randy D Gascoyne; Adrian Wiestner; Dana Masin; Marcel B Bally; Michael E Williams
Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Leukemia research 2006;30(4):449-57.
2006: Lincoln A Edwards; Maite Verreault; Brian Thiessen; Wieslawa H Dragowska; Yanping Hu; Juliana H F Yeung; Shoukat Dedhar; Marcel B Bally
Combined inhibition of the phosphatidylinositol 3-kinase/Akt and Ras/mitogen-activated protein kinase pathways results in synergistic effects in glioblastoma cells.
Molecular cancer therapeutics 2006;5(3):645-54.
2006: Armelle A Troussard; Paul C McDonald; Elizabeth D Wederell; Nasrin M Mawji; Nolan R Filipenko; Karen Gelmon; Jill E Kucab; Sandra E Dunn; Joanne T Emerman; Marcel B Bally; Shoukat Dedhar
Preferential dependence of breast cancer cells versus normal cells on integrin-linked kinase for protein kinase B/Akt activation and cell survival.
Cancer research 2006;66(1):393-403.
2005: Euan C Ramsay; Nancy Dos Santos; Wieslawa H Dragowska; Janessa J Laskin; Marcel B Bally
The formulation of lipid-based nanotechnologies for the delivery of fixed dose anticancer drug combinations.
Current drug delivery 2005;2(4):341-51.
2005: Nancy Dos Santos; Dawn Waterhouse; Dana Masin; Paul G Tardi; Göran Karlsson; Katarina Edwards; Marcel B Bally
Substantial increases in idarubicin plasma concentration by liposome encapsulation mediates improved antitumor activity.
Journal of controlled release : official journal of the Controlled Release Society 2005;105(1-2):89-105.
2005: Dawn Waterhouse; Tetyana Denyssevych; Norma Hudon; Stephen Chia; Karen Gelmon; Marcel B Bally
Trastuzumab and liposomal Doxorubicin in the treatment of mcf-7 xenograft tumor-bearing mice: combination does not affect drug serum levels.
Pharmaceutical research 2005;22(6):915-22.
2005: Lincoln A Edwards; B Thiessen; Wieslawa H Dragowska; Tim Daynard; Marcel B Bally; Shoukat Dedhar
Inhibition of ILK in PTEN-mutant human glioblastomas inhibits PKB/Akt activation, induces apoptosis, and delays tumor growth.
Oncogene 2005;24(22):3596-605.
2005: Gigi Chiu; Sheela A Abraham; Ludger M Ickenstein; Rebecca Ng; Göran Karlsson; Katarina Edwards; Ellen K Wasan; Marcel B Bally
Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese.
Journal of controlled release : official journal of the Controlled Release Society 2005;104(2):271-88.
2005: Sheela A Abraham; Dawn Waterhouse; Lawrence D Mayer; Pieter R Cullis; Thomas D Madden; Marcel B Bally
The liposomal formulation of doxorubicin.
Methods in enzymology 2005;391():71-97.
2005: Dawn Waterhouse; Thomas D Madden; Pieter R Cullis; Marcel B Bally; Lawrence D Mayer; Murray S Webb
Preparation, characterization, and biological analysis of liposomal formulations of vincristine.
Methods in enzymology 2005;391():40-57.
2004: YanPing Hu; Gwyn Bebb; Sophia Tan; Rebecca Ng; Hong Yan; Jason R Sartor; Lawrence D Mayer; Marcel B Bally
Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(22):7662-70.
2004: Wieslawa H Dragowska; Corinna Warburton; Donald T T Yapp; Andrew I Minchinton; Yanping Hu; Dawn Waterhouse; Karen Gelmon; Kirsten Skov; Janet Woo; Dana Masin; Lynsey A Huxham; Alastair H Kyle; Marcel B Bally
HER-2/neu overexpression increases the viable hypoxic cell population within solid tumors without causing changes in tumor vascularization.
Molecular cancer research : MCR 2004;2(11):606-19.
2004: Corrie Lynn Messerer; Euan C Ramsay; Dawn Waterhouse; Rebecca Ng; Eva-Maria Simms; Natashia Harasym; Paul G Tardi; Lawrence D Mayer; Marcel B Bally
Liposomal irinotecan: formulation development and therapeutic assessment in murine xenograft models of colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(19):6638-49.
2004: Benjamin L Viglianti; Sheela A Abraham; Charles R Michelich; Pavel Yarmolenko; James R MacFall; Marcel B Bally; Mark Dewhirst
In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: illustration of targeted delivery.
Magnetic resonance in medicine : official journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine 2004;51(6):1153-62.
2004: Sheela A Abraham; Katarina Edwards; Göran Karlsson; Norma Hudon; Lawrence D Mayer; Marcel B Bally
An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes.
Journal of controlled release : official journal of the Controlled Release Society 2004;96(3):449-61.
2004: Marie-Paule Schutze-Redelmeier; Spencer Kong; Marcel B Bally; Jan P Dutz
Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes.
Vaccine 2004;22(15-16):1985-91.
2004: Corinna Warburton; Wieslawa H Dragowska; Karen Gelmon; Stephen Chia; Hong Yan; Dana Masin; Tetyana Denyssevych; Anne E Wallis; Marcel B Bally
Treatment of HER-2/neu overexpressing breast cancer xenograft models with trastuzumab (Herceptin) and gefitinib (ZD1839): drug combination effects on tumor growth, HER-2/neu and epidermal growth factor receptor expression, and viable hypoxic cell fraction.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2512-24.
2004: Nancy Dos Santos; Kelly A K Cox; Cheryl A McKenzie; Floris van Baarda; Ryan C Gallagher; Göran Karlsson; Katarina Edwards; Lawrence D Mayer; Christine Allen; Marcel B Bally
pH gradient loading of anthracyclines into cholesterol-free liposomes: enhancing drug loading rates through use of ethanol.
Biochimica et biophysica acta 2004;1661(1):47-60.
2004: YanPing Hu; AWTAR KRISHAN; WeiJia Nie; Kasi S Sridhar; Lawrence D Mayer; Marcel B Bally
Synergistic cytotoxicity of pyrazoloacridine with doxorubicin, etoposide, and topotecan in drug-resistant tumor cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):1160-9.
2004: Dawn Waterhouse; Wieslawa H Dragowska; Karen Gelmon; Lawrence D Mayer; Marcel B Bally
Pharmacodynamic behavior of liposomal antisense oligonucleotides targeting Her-2/neu and vascular endothelial growth factor in an ascitic MDA435/LCC6 human breast cancer model.
Cancer biology & therapy 2004;3(2):197-204.
2004: Sheela A Abraham; Cheryl McKenzie; Dana Masin; Rebecca Ng; Troy O Harasym; Lawrence D Mayer; Marcel B Bally
In vitro and in vivo characterization of doxorubicin and vincristine coencapsulated within liposomes through use of transition metal ion complexation and pH gradient loading.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(2):728-38.
2004: Lincoln A Edwards; Jennifer A Shabbits; Marcel B Bally; Shoukat Dedhar
Integrin-linked kinase (ILK) in combination molecular targeting.
Cancer treatment and research 2004;119():59-75.
2003: Dawn Waterhouse; Karen Gelmon; Dana Masin; Marcel B Bally
Combining doxorubicin and liposomal anti-HER-2/NEU antisense oligodeoxynucleotides to treat HER-2/NEU-expressing MDA-MB-435 breast tumor model.
Journal of experimental therapeutics & oncology 2003;3(5):261-71.
2003: Wai Ming Li; Wieslawa H Dragowska; Marcel B Bally; Marie-Paule Schutze-Redelmeier
Effective induction of CD8+ T-cell response using CpG oligodeoxynucleotides and HER-2/neu-derived peptide co-encapsulated in liposomes.
Vaccine 2003;21(23):3319-29.
2003: Yanping Hu; Marcel B Bally; Wieslawa H Dragowska; Lawrence Mayer
Inhibition of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase enhances chemotherapeutic effects on H460 human non-small cell lung cancer cells through activation of apoptosis.
Molecular cancer therapeutics 2003;2(7):641-9.
2003: Gigi Chiu; Marcel B Bally; Lawrence D Mayer
Targeting of antibody conjugated, phosphatidylserine-containing liposomes to vascular cell adhesion molecule 1 for controlled thrombogenesis.
Biochimica et biophysica acta 2003;1613(1-2):115-21.
2003: F M P Wong; P Harvie; Yuanpeng Zhang; E C Ramsay; Marcel B Bally
Phosphatidylethanolamine mediated destabilization of lipid-based pDNA delivery systems.
International journal of pharmaceutics 2003;255(1-2):117-27.
2002: Ghania Chikh; Wai Ming Li; Marie-Paule Schutze-Redelmeier; Jean-Claude Meunier; Marcel B Bally
Attaching histidine-tagged peptides and proteins to lipid-based carriers through use of metal-ion-chelating lipids.
Biochimica et biophysica acta 2002;1567(1-2):204-12.
2002: F M P Wong; S A MacAdam; A Kim; C Oja; E C Ramsay; Marcel B Bally
A lipid-based delivery system for antisense oligonucleotides derived from a hydrophobic complex.
Journal of drug targeting 2002;10(8):615-23.
2002: Sheela A Abraham; Katarina Edwards; Göran Karlsson; Scott MacIntosh; Lawrence D Mayer; Cheryl McKenzie; Marcel B Bally
Formation of transition metal-doxorubicin complexes inside liposomes.
Biochimica et biophysica acta 2002;1565(1):41-54.
2002: Qiang Hu; Marcel B Bally; Thomas D Madden
Subcellular trafficking of antisense oligonucleotides and down-regulation of bcl-2 gene expression in human melanoma cells using a fusogenic liposome delivery system.
Nucleic acids research 2002;30(16):3632-41.
2002: Ellen K Wasan; Dawn Waterhouse; Olena Sivak; Marcel B Bally; Richard J Klasa; Kishor M Wasan
Plasma protein binding, lipoprotein distribution and uptake of free and lipid-associated BCL-2 antisense oligodeoxynucleotides (G3139) in human melanoma cells.
International journal of pharmaceutics 2002;241(1):57-64.
2002: Nancy Dos Santos; Lawrence D Mayer; Sheela A Abraham; Ryan C Gallagher; Kelly A K Cox; Paul G Tardi; Marcel B Bally
Improved retention of idarubicin after intravenous injection obtained for cholesterol-free liposomes.
Biochimica et biophysica acta 2002;1561(2):188-201.
2002: Christine Allen; Nancy Dos Santos; R Gallagher; Gigi Chiu; Y Shu; W M Li; Sharon A Johnstone; Andrew S Janoff; Lawrence D Mayer; Murray S Webb; Marcel B Bally
Controlling the physical behavior and biological performance of liposome formulations through use of surface grafted poly(ethylene glycol).
Bioscience reports 2002;22(2):225-50.
2002: Emma S Guns; Tetyana Denyssevych; Ross Dixon; Marcel B Bally; Lawrence Mayer
Drug interaction studies between paclitaxel (Taxol) and OC144-093--a new modulator of MDR in cancer chemotherapy.
European journal of drug metabolism and pharmacokinetics 2002;27(2):119-26.
2002: Wai Ming Li; Lawrence D Mayer; Marcel B Bally
Prevention of antibody-mediated elimination of ligand-targeted liposomes by using poly(ethylene glycol)-modified lipids.
The Journal of pharmacology and experimental therapeutics 2002;300(3):976-83.
2002: Gigi Chiu; Marcel B Bally; Lawrence D Mayer
Effects of phosphatidylserine on membrane incorporation and surface protection properties of exchangeable poly(ethylene glycol)-conjugated lipids.
Biochimica et biophysica acta 2002;1560(1-2):37-50.
2001: Ghania Chikh; S Kong; Marcel B Bally; J C Meunier; Marie-Paule Schutze-Redelmeier
Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(11):6462-70.
2001: Wai Ming Li; Marcel B Bally; Marie-Paule Schutze-Redelmeier
Enhanced immune response to T-independent antigen by using CpG oligodeoxynucleotides encapsulated in liposomes.
Vaccine 2001;20(1-2):148-57.
2001: Emma S Guns; P L Bullock; M L Reimer; R Dixon; Marcel B Bally; Lawrence D Mayer
Assessment of the involvement of CYP3A in the vitro metabolism of a new modulator of MDR in cancer chemotherapy, OC144-193, by human liver microsomes.
European journal of drug metabolism and pharmacokinetics 2001;26(4):273-82.
2001: Q Hu; Clifford R Shew; Marcel B Bally; Thomas D Madden
Programmable fusogenic vesicles for intracellular delivery of antisense oligodeoxynucleotides: enhanced cellular uptake and biological effects.
Biochimica et biophysica acta 2001;1514(1):1-13.
2001: Dawn Waterhouse; N Dos Santos; Lawrence D Mayer; Marcel B Bally
Drug-drug interactions arising from the use of liposomal vincristine in combination with other anticancer drugs.
Pharmaceutical research 2001;18(9):1331-5.
2001: Wai Ming Li; L Xue; Lawrence D Mayer; Marcel B Bally
Intermembrane transfer of polyethylene glycol-modified phosphatidylethanolamine as a means to reveal surface-associated binding ligands on liposomes.
Biochimica et biophysica acta 2001;1513(2):193-206.
2001: Ghania Chikh; Marcel B Bally; Marie-Paule Schutze-Redelmeier
Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes.
Journal of immunological methods 2001;254(1-2):119-35.
2001: S A Johnstone; Dana Masin; L Mayer; Marcel B Bally
Surface-associated serum proteins inhibit the uptake of phosphatidylserine and poly(ethylene glycol) liposomes by mouse macrophages.
Biochimica et biophysica acta 2001;1513(1):25-37.
2001: M Wong; S Kong; Wieslawa H Dragowska; Marcel B Bally
Oxazole yellow homodimer YOYO-1-labeled DNA: a fluorescent complex that can be used to assess structural changes in DNA following formation and cellular delivery of cationic lipid DNA complexes.
Biochimica et biophysica acta 2001;1527(1-2):61-72.
2001: Gigi Chiu; Marcel B Bally; Lawrence D Mayer
Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol).
Biochimica et biophysica acta 2001;1510(1-2):56-69.
2001: Dawn Waterhouse; Paul G Tardi; Lawrence D Mayer; Marcel B Bally
A comparison of liposomal formulations of doxorubicin with drug administered in free form: changing toxicity profiles.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(12):903-20.
2000: HJ Lim; M J Parr; Dana Masin; NL McIntosh; Thomas D Madden; G Zhang; S Johnstone; Marcel B Bally
Kupffer cells do not play a role in governing the efficacy of liposomal mitoxantrone used to treat a tumor model designed to assess drug delivery to liver.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(11):4449-60.
2000: Paul G Tardi; E Choice; Dana Masin; T Redelmeier; Marcel B Bally; Thomas D Madden
Liposomal encapsulation of topotecan enhances anticancer efficacy in murine and human xenograft models.
Cancer research 2000;60(13):3389-93.
2000: Richard J Klasa; Marcel B Bally; R Ng; J H Goldie; Randy D Gascoyne; F M P Wong
Eradication of human non-Hodgkin's lymphoma in SCID mice by BCL-2 antisense oligonucleotides combined with low-dose cyclophosphamide.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(6):2492-500.
2000: P Harvie; F M P Wong; Marcel B Bally
Use of poly(ethylene glycol)-lipid conjugates to regulate the surface attributes and transfection activity of lipid-DNA particles.
Journal of pharmaceutical sciences 2000;89(5):652-63.
2000: HJ Lim; Dana Masin; NL McIntosh; Thomas D Madden; Marcel B Bally
Role of drug release and liposome-mediated drug delivery in governing the therapeutic activity of liposomal mitoxantrone used to treat human A431 and LS180 solid tumors.
The Journal of pharmacology and experimental therapeutics 2000;292(1):337-45.
1999: Ellen K Wasan; P Harvie; Katarina Edwards; Göran Karlsson; Marcel B Bally
A multi-step lipid mixing assay to model structural changes in cationic lipoplexes used for in vitro transfection.
Biochimica et biophysica acta 1999;1461(1):27-46.
1999: G Adlakha-Hutcheon; Marcel B Bally; Clifford R Shew; Thomas D Madden
Controlled destabilization of a liposomal drug delivery system enhances mitoxantrone antitumor activity.
Nature biotechnology 1999;17(8):775-9.
1999: F M P Wong; Marcel B Bally; Donald E Brooks
Electrostatically mediated interactions between cationic lipid-DNA particles and an anionic surface.
Archives of biochemistry and biophysics 1999;366(1):31-9.
1999: DL Reimer; S Kong; MA Monck; J Wyles; P Tam; Ellen K Wasan; Marcel B Bally
Liposomal lipid and plasmid DNA delivery to B16/BL6 tumors after intraperitoneal administration of cationic liposome DNA aggregates.
The Journal of pharmacology and experimental therapeutics 1999;289(2):807-15.
1999: Karen Gelmon; Anthony W Tolcher; A R Diab; Marcel B Bally; L Embree; Norma Hudon; C Dedhar; D Ayers; A Eisen; B Melosky; C Burge; P Logan; Lawrence D Mayer
Phase I study of liposomal vincristine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):697-705.
1998: P Harvie; F M P Wong; Marcel B Bally
Characterization of lipid DNA interactions. I. Destabilization of bound lipids and DNA dissociation.
Biophysical journal 1998;75(2):1040-51.
1998: Murray S Webb; D Saxon; F M P Wong; H J Lim; Z Wang; Marcel B Bally; L S Choi; P R Cullis; Lawrence D Mayer
Comparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine.
Biochimica et biophysica acta 1998;1372(2):272-82.
1998: Murray S Webb; P Logan; P M Kanter; G St-Onge; Karen Gelmon; Troy O Harasym; Lawrence D Mayer; Marcel B Bally
Preclinical pharmacology, toxicology and efficacy of sphingomyelin/cholesterol liposomal vincristine for therapeutic treatment of cancer.
Cancer chemotherapy and pharmacology 1998;42(6):461-70.
1998: L Embree; Karen Gelmon; Anthony W Tolcher; Norma Hudon; JR Heggie; C Dedhar; P Logan; Marcel B Bally; Lawrence D Mayer
Pharmacokinetic behavior of vincristine sulfate following administration of vincristine sulfate liposome injection.
Cancer chemotherapy and pharmacology 1998;41(5):347-52.
1998: Ellen K Wasan; A Fairchild; Marcel B Bally
Cationic liposome--plasmid DNA complexes used for gene transfer retain a significant trapped volume.
Journal of pharmaceutical sciences 1998;87(1):9-14.
1997: Paul G Tardi; E N Swartz; Troy O Harasym; Pieter R Cullis; Marcel B Bally
An immune response to ovalbumin covalently coupled to liposomes is prevented when the liposomes used contain doxorubicin.
Journal of immunological methods 1997;210(2):137-48.
1997: L Embree; Karen Gelmon; Anthony W Tolcher; Norma Hudon; JR Heggie; C Dedhar; Murray S Webb; Marcel B Bally; Lawrence D Mayer
Validation of a high-performance liquid chromatographic assay method for quantification of total vincristine sulfate in human plasma following administration of vincristine sulfate liposome injection.
Journal of pharmaceutical and biomedical analysis 1997;16(4):675-87.
1997: Pieter R Cullis; Michael J Hope; Marcel B Bally; Thomas D Madden; Lawrence D Mayer; David B Fenske
Influence of pH gradients on the transbilayer transport of drugs, lipids, peptides and metal ions into large unilamellar vesicles.
Biochimica et biophysica acta 1997;1331(2):187-211.
1997: DL Reimer; S Kong; Marcel B Bally
Analysis of cationic liposome-mediated interactions of plasmid DNA with murine and human melanoma cells in vitro.
The Journal of biological chemistry 1997;272(31):19480-7.
1997: HJ Lim; Dana Masin; Thomas D Madden; Marcel B Bally
Influence of drug release characteristics on the therapeutic activity of liposomal mitoxantrone.
The Journal of pharmacology and experimental therapeutics 1997;281(1):566-73.
1997: Lawrence D Mayer; Graeme Dougherty; Troy O Harasym; Marcel B Bally
The role of tumor-associated macrophages in the delivery of liposomal doxorubicin to solid murine fibrosarcoma tumors.
The Journal of pharmacology and experimental therapeutics 1997;280(3):1406-14.
1997: M J Parr; Dana Masin; Pieter R Cullis; Marcel B Bally
Accumulation of liposomal lipid and encapsulated doxorubicin in murine Lewis lung carcinoma: the lack of beneficial effects by coating liposomes with poly(ethylene glycol).
The Journal of pharmacology and experimental therapeutics 1997;280(3):1319-27.
1997: Yuanpeng Zhang; DL Reimer; G Zhang; P H Lee; Marcel B Bally
Self-assembling DNA-lipid particles for gene transfer.
Pharmaceutical research 1997;14(2):190-6.
1997: Troy O Harasym; Pieter R Cullis; Marcel B Bally
Intratumor distribution of doxorubicin following i.v. administration of drug encapsulated in egg phosphatidylcholine/cholesterol liposomes.
Cancer chemotherapy and pharmacology 1997;40(4):309-17.
1997: C W Chang; L Barber; C Ouyang; Dana Masin; Marcel B Bally; Thomas D Madden
Plasma clearance, biodistribution and therapeutic properties of mitoxantrone encapsulated in conventional and sterically stabilized liposomes after intravenous administration in BDF1 mice.
British journal of cancer 1997;75(2):169-77.
1996: F M P Wong; D L Reimer; Marcel B Bally
Cationic lipid binding to DNA: characterization of complex formation.
Biochemistry 1996;35(18):5756-63.
1996: Ellen K Wasan; D L Reimer; Marcel B Bally
Plasmid DNA is protected against ultrasonic cavitation-induced damage when complexed to cationic liposomes.
Journal of pharmaceutical sciences 1996;85(4):427-33.
1996: N L Boman; V A Tron; Marcel B Bally; Pieter R Cullis
Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes.
Cancer chemotherapy and pharmacology 1996;37(4):351-5.
1995: S A Longman; P G Tardi; M J Parr; L Choi; Pieter R Cullis; Marcel B Bally
Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes.
The Journal of pharmacology and experimental therapeutics 1995;275(3):1177-84.
1995: E Choice; Dana Masin; Marcel B Bally; M Meloche; Thomas D Madden
Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution.
Transplantation 1995;60(9):1006-11.
1995: D L Reimer; Y Zhang; S Kong; J J Wheeler; RW Graham; Marcel B Bally
Formation of novel hydrophobic complexes between cationic lipids and plasmid DNA.
Biochemistry 1995;34(39):12877-83.
1995: Murray S Webb; Troy O Harasym; Dana Masin; Marcel B Bally; Lawrence D Mayer
Sphingomyelin-cholesterol liposomes significantly enhance the pharmacokinetic and therapeutic properties of vincristine in murine and human tumour models.
British journal of cancer 1995;72(4):896-904.
1995: Murray S Webb; J J Wheeler; Marcel B Bally; Lawrence D Mayer
The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery.
Biochimica et biophysica acta 1995;1238(2):147-55.
1995: Lawrence D Mayer; Dana Masin; R Nayar; N L Boman; Marcel B Bally
Pharmacology of liposomal vincristine in mice bearing L1210 ascitic and B16/BL6 solid tumours.
British journal of cancer 1995;71(3):482-8.
1995: Troy O Harasym; P Tardi; S A Longman; Steven M Ansell; Marcel B Bally; Pieter R Cullis; L S Choi
Poly(ethylene glycol)-modified phospholipids prevent aggregation during covalent conjugation of proteins to liposomes.
Bioconjugate chemistry 1995;6(2):187-94.
1995: S A Longman; Pieter R Cullis; L Choi; G de Jong; Marcel B Bally
A two-step targeting approach for delivery of doxorubicin-loaded liposomes to tumour cells in vivo.
Cancer chemotherapy and pharmacology 1995;36(2):91-101.
1994: J J Wheeler; Kim F Wong; Steven M Ansell; Dana Masin; Marcel B Bally
Polyethylene glycol modified phospholipids stabilize emulsions prepared from triacylglycerol.
Journal of pharmaceutical sciences 1994;83(11):1558-64.
1994: N L Boman; Dana Masin; Lawrence D Mayer; Pieter R Cullis; Marcel B Bally
Liposomal vincristine which exhibits increased drug retention and increased circulation longevity cures mice bearing P388 tumors.
Cancer research 1994;54(11):2830-3.
1994: Marcel B Bally; Dana Masin; R Nayar; Pieter R Cullis; Lawrence D Mayer
Transfer of liposomal drug carriers from the blood to the peritoneal cavity of normal and ascitic tumor-bearing mice.
Cancer chemotherapy and pharmacology 1994;34(2):137-46.
1993: M J Parr; Marcel B Bally; Pieter R Cullis
The presence of GM1 in liposomes with entrapped doxorubicin does not prevent RES blockade.
Biochimica et biophysica acta 1993;1168(2):249-52.
1993: Lawrence D Mayer; R Nayar; RL Thies; N L Boman; Pieter R Cullis; Marcel B Bally
Identification of vesicle properties that enhance the antitumour activity of liposomal vincristine against murine L1210 leukemia.
Cancer chemotherapy and pharmacology 1993;33(1):17-24.
1991: Pieter R Cullis; Marcel B Bally; Thomas D Madden; Lawrence D Mayer; Michael J Hope
pH gradients and membrane transport in liposomal systems.
Trends in biotechnology 1991;9(8):268-72.
1990: H C Loughrey; Kim F Wong; L S Choi; Pieter R Cullis; Marcel B Bally
Protein-liposome conjugates with defined size distributions.
Biochimica et biophysica acta 1990;1028(1):73-81.
1990: H C Loughrey; L S Choi; Pieter R Cullis; Marcel B Bally
Optimized procedures for the coupling of proteins to liposomes.
Journal of immunological methods 1990;132(1):25-35.
1990: H C Loughrey; Marcel B Bally; L W Reinish; Pieter R Cullis
The binding of phosphatidylglycerol liposomes to rat platelets is mediated by complement.
Thrombosis and haemostasis 1990;64(1):172-6.
1990: RL Thies; D W Cowens; Pieter R Cullis; Marcel B Bally; Lawrence D Mayer
Method for rapid separation of liposome-associated doxorubicin from free doxorubicin in plasma.
Analytical biochemistry 1990;188(1):65-71.
1990: Lawrence D Mayer; L C Tai; Marcel B Bally; G N Mitilenes; R S Ginsberg; Pieter R Cullis
Characterization of liposomal systems containing doxorubicin entrapped in response to pH gradients.
Biochimica et biophysica acta 1990;1025(2):143-51.
1990: Marcel B Bally; R Nayar; Dana Masin; M J Hope; Pieter R Cullis; Lawrence D Mayer
Liposomes with entrapped doxorubicin exhibit extended blood residence times.
Biochimica et biophysica acta 1990;1023(1):133-9.
1990: Thomas D Madden; P R Harrigan; L C Tai; Marcel B Bally; Lawrence D Mayer; T E Redelmeier; H C Loughrey; C P Tilcock; L W Reinish; Pieter R Cullis
The accumulation of drugs within large unilamellar vesicles exhibiting a proton gradient: a survey.
Chemistry and physics of lipids 1990;53(1):37-46.
1990: Lawrence D Mayer; Marcel B Bally; H Loughrey; Dana Masin; Pieter R Cullis
Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
Cancer research 1990;50(3):575-9.
1990: Marcel B Bally; R Nayar; Dana Masin; Pieter R Cullis; Lawrence D Mayer
Studies on the myelosuppressive activity of doxorubicin entrapped in liposomes.
Cancer chemotherapy and pharmacology 1990;27(1):13-9.
1989: Lawrence D Mayer; L C Tai; Dicken S. C. Ko; Dana Masin; R S Ginsberg; Pieter R Cullis; Marcel B Bally
Influence of vesicle size, lipid composition, and drug-to-lipid ratio on the biological activity of liposomal doxorubicin in mice.
Cancer research 1989;49(21):5922-30.
1989: T E Redelmeier; Lawrence D Mayer; Kim F Wong; Marcel B Bally; Pieter R Cullis
Proton flux in large unilamellar vesicles in response to membrane potentials and pH gradients.
Biophysical journal 1989;56(2):385-93.
1989: Claire Doerschuk; R P Gie; Marcel B Bally; Pieter R Cullis; L W Reinish
Platelet distribution in rabbits following infusion of liposomes.
Thrombosis and haemostasis 1989;61(3):392-6.
1989: J A Balazsovits; Lawrence D Mayer; Marcel B Bally; Pieter R Cullis; M McDonell; R S Ginsberg; R E Falk
Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin.
Cancer chemotherapy and pharmacology 1989;23(2):81-6.
1988: L W Reinish; Marcel B Bally; H C Loughrey; Pieter R Cullis
Interactions of liposomes and platelets.
Thrombosis and haemostasis 1988;60(3):518-23.
1988: Marcel B Bally; Lawrence D Mayer; H Loughrey; T Redelmeier; Thomas D Madden; K Wong; P R Harrigan; Michael J Hope; Pieter R Cullis
Dopamine accumulation in large unilamellar vesicle systems induced by transmembrane ion gradients.
Chemistry and physics of lipids 1988;47(2):97-107.
1987: H Loughrey; Marcel B Bally; Pieter R Cullis
A non-covalent method of attaching antibodies to liposomes.
Biochimica et biophysica acta 1987;901(1):157-60.
1985: Thomas D Madden; Marcel B Bally; Michael J Hope; Pieter R Cullis; H P Schieren; AS Janoff
Protection of large unilamellar vesicles by trehalose during dehydration: retention of vesicle contents.
Biochimica et biophysica acta 1985;817(1):67-74.
1985: Michael J Hope; G Webb; Marcel B Bally; Pieter R Cullis
Production of large unilamellar vesicles by a rapid extrusion procedure: characterization of size distribution, trapped volume and ability to maintain a membrane potential.
Biochimica et biophysica acta 1985;812(1):55-65.